| Literature DB >> 30908914 |
Serge Lavoie1,2, Anne Marie Sweeney-Jones1, Nazia Mojib1, Brandon Dale3, Kerstin Gagaring4, Case W McNamara4, Cassandra L Quave3, Katy Soapi5, Julia Kubanek1,6.
Abstract
A series of oligomeric phenols including the known natural product 3,4,3',4'-tetrahydroxy-1,1'-biphenyl (3), the previously synthesized 2,3,8,9-tetrahydroxybenzo[ c]chromen-6-one (4), and eight new related natural products, cladophorols B-I (5-12), were isolated from the Fijian green alga Cladophora socialis and identified by a combination of NMR spectroscopy, mass spectrometric analysis, and computational modeling using DFT calculations. J-resolved spectroscopy and line width reduction by picric acid addition aided in resolving the heavily overlapped aromatic signals. A panel of Gram-positive and Gram-negative pathogens used to evaluate pharmacological potential led to the determination that cladophorol C (6) exhibits potent antibiotic activity selective toward methicillin-resistant Staphylococcus aureus (MRSA) with an MIC of 1.4 μg/mL. Cladophorols B (5) and D-H (7-11) had more modest but also selective antibiotic potency. Activities of cladophorols A-I (4-12) were also assessed against the asexual blood stages of Plasmodium falciparum and revealed cladophorols A (4) and B (5) to have modest activity with EC50 values of 0.7 and 1.9 μg/mL, respectively.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30908914 PMCID: PMC6503470 DOI: 10.1021/acs.joc.8b03218
Source DB: PubMed Journal: J Org Chem ISSN: 0022-3263 Impact factor: 4.354
Figure 1Structures of compounds 3–12 from C. socialis.
1H (800 MHz) and 13C (200 MHz) NMR Spectroscopic Data of Cladophorols A and B (4–5) in CD3OD
| position | δC | δH | δC | δH |
|---|---|---|---|---|
| Benzo[ | ||||
| 1 | 107.4 (d) | 7.32 s | 108.2 (d) | 8.37 d (2.8) |
| 2 | 144.4 (s) | 155.6 (s) | ||
| 3 | 148.6 (s) | 106.9 (d) | 6.69 d (2.8) | |
| 4 | 104.4 (d) | 6.73 s | 146.6 (s) | |
| 4a | 146.0 (s) | 136.3 (s) | ||
| 6 | 164.0 (s) | 163.4 (s) | ||
| 6a | 112.9 (s) | 114.5 (s) | ||
| 7 | 115.4 (d) | 7.58 s | 123.9 (d) | 7.84 d (8.5) |
| 8 | 147.3 (s) | 116.4 (d) | 7.08 d (8.5) | |
| 9 | 154.8 (s) | 152.7 (s) | ||
| 10 | 108.3 (d) | 7.33 s | 144.3 (s) | |
| 10a | 131.7 (s) | 123.1 (s) | ||
| 10b | 111.4 (s) | 120.7 (s) | ||
| Biphenyl | ||||
| 1A | 139.6 (s) | |||
| 2A | 116.0 (d) | 7.14 d (2.2) | ||
| 3A | 150.1 (s) | |||
| 4A | 144.0 (s) | |||
| 5A | 122.1 (d) | 6.98 d (8.3) | ||
| 6A | 119.1 (d) | 7.02 dd (8.3, 2.2) | ||
| 1B | 133.9 (s) | |||
| 2B | 114.9 (d) | 7.04 d (2.2) | ||
| 3B | 146.5 (s) | |||
| 4B | 145.9 (s) | |||
| 5B | 116.6 (d) | 6.82 d (8.2) | ||
| 6B | 119.2 (d) | 6.93 dd (8.2, 2.2) | ||
Figure 2Possible structures (a and b) for cladophorol A (4) based on selected observed HMBC correlations indicated by arrows.
Figure 3Original and hypothetical structures proposed for 1, supporting reassignment of previously published 1 as 13.
Experimental and Calculated NMR Chemical Shifts for 1, 13, and 14
δ values calculated at the mPW1PW91/6-311+G(d,p)//B3LYP/6-31G(d) level of theory performed with the polarizable continuum model (PCM) using DMSO. Red color highlights large differences in calculated values: |ΔδH| > 0.2, |ΔδC| > 3.0.
Root-mean-square deviation.
Maximum absolute error.
DP4+ probability.[21]
1H (800 MHz) and 13C (200 MHz) NMR Spectroscopic Data of Cladophorols C and D (6–7) in CD3OD
| position | δC | δH | δC | δH |
|---|---|---|---|---|
| Rings A–B (Biphenyl) | ||||
| 1A | 134.0 | 134.0 | ||
| 2A | 114.9 | 7.01 (d, 2.2) | 114.9 | 7.01 (d, 2.2) |
| 3A | 146.5 | 146.5 | ||
| 4A | 146.0 | 146.0 | ||
| 5A | 116.6 | 6.81 (d, 8.2) | 116.6 | 6.81 (d, 8.2) |
| 6A | 119.3 | 6.912 (dd, 8.2, 2.2) | 119.3 | 6.912 (dd, 8.2, 2.3) |
| 1B | 139.9 | 139.9 | ||
| 2B | 116.1 | 7.11 (d, 2.2) | 116.1 | 7.11 (d, 2.2) |
| 3B | 150.2 | 150.2 | ||
| 4B | 143.9 | 143.9 | ||
| 5B | 122.3 | 6.94 (d, 8.3) | 122.2 | 6.94 (d, 8.3) |
| 6B | 119.2 | 7.00 (dd, 8.3, 2.2) | 119.2 | 7.00 (dd, 8.3, 2.2) |
| Ring C | ||||
| 1 | 139.8 | 139.87 | ||
| 2 | 151.3 | 151.3 | ||
| 3 | 107.0 | 6.57 (d, 2.9) | 107.0 | 6.58 (d, 2.9) |
| 4 | 157.0 | 157.0 | ||
| 5 | 109.4 | 6.47 (dd, 8.8, 2.9) | 109.4 | 6.47 (dd, 8.8, 2.9) |
| 6 | 123.2 | 6.905 (dd, 8.8) | 123.2 | 6.905 (dd, 8.8) |
| Middle Rings | ||||
| 1 | 139.7, 139.54, 139.53, 139.50 | 139.76, 139.57, 139.55, 139.52 (2×) | ||
| 2 | 151.25, 151.23, 151.21, 151.1 | 151.26, 151.24, 151.23, 151.21, 151.1 | ||
| 3 | 106.5, 106.36, 106.34, 106.31 | 6.53, 6.51, 6.503, 6.496 (all d, 2.9) | 106.5 (2×), 106.37, 106.36, 106.33 | 6.53, 6.512, 6.51, 6.503, 6.497 (all d, 2.9) |
| 4 | 157.6, 157.54, 157.51, 157.4, | 157.6 (2×), 157.54, 157.51, 157.4 | ||
| 5 | 108.8, 108.77, 108.75, 108.74 | 6.42, 6.41, 6.40, 6.39 (all dd, 8.8, 2.9) | 108.8, 108.78, 108.77 (2×), 108.75 | 6.423, 6.41, 6.40, 6.399, 6.388 (all dd, 8.8, 2.9), |
| 6 | 123.19 (2×), 123.14, 122.9 | 6.88, 6.87, 6.86, 6.84 (all d, 8.8) | 123.19 (2×), 123.17, 123.13, 122.9 | 6.88, 6.87, 6.868, 6.863, 6.84 (all d, 8.8) |
| Ring Y | ||||
| 1 | 141.0 | 141.0 | ||
| 2 | 150.6 | 150.6 | ||
| 3 | 106.34 | 6.48 (d, 2.9) | 106.36 | 6.48 (d, 2.9) |
| 4 | 156.7 | 156.7 | ||
| 5 | 108.66 | 6.34 (dd, 8.8, 2.9) | 108.68 | 6.34 (dd, 8.8, 2.9) |
| 6 | 121.7 | 6.74 (d, 8.8) | 121.7 | 6.74 (d, 8.8) |
| Ring Z | ||||
| 1 | 141.7 | 141.7 | ||
| 2 | 147.0 | 147.0 | ||
| 3 | 106.4 | 6.42 (d, 2.9) | 106.45 | 6.420 (d, 2.9) |
| 4 | 152.9 | 152.9 | ||
| 5 | 109.1 | 6.27 (dd, 8.6, 2.9) | 109.1 | 6.27 (d, 8.6, 2.9) |
| 6 | 116.4 | 6.67 (d, 8.6) | 116.4 | 6.67 (d, 8.6) |
Rings Y and Z are the last two rings of the oligomer.
13C signal can be interchanged with one of the corresponding signals of rings D–G.
Figure 4Gradient of NMR chemical shift along the oligomer of 1,2,4-trihydroxyphenyl units for cladophorol C (6). Experimental (black) and simulated (colored) signals are shown.
Figure 5Hypothetical structures for cladophorol C (6a and 6b) and model structures 15a and 15b.
Figure 6Chemical shift spreading for cladophorol C (6) and cladophorol E (8) for position H-6. The limited spreading of 8 suggest an end-capping of the oligomer. Simulated (blue) and experimental (gray) signals are shown.
13C (200 MHz) NMR Spectroscopic Data of Cladophorols E–I (8–12) in CD3OD
| position | |||||
|---|---|---|---|---|---|
| Rings A–B (Biphenyl) | |||||
| 1A | 134.0 | 134.0 | 134.0 | 134.0 | 134.0 |
| 2A | 114.9 | 114.9 | 114.9 | 114.9 | 114.9 |
| 3A | 146.5 | 146.5 | 146.5 | 146.5 | 146.5 |
| 4A | 146.0 | 146.0 | 146.0 | 146.0 | 146.0 |
| 5A | 116.6 | 116.7 | 116.6 | 116.6 | 116.6 |
| 6A | 119.3 | 119.3 | 119.3 | 119.3 | 119.3 |
| 1B | 139.93 | 139.91 | 139.92 | 139.92 | 139.93 |
| 2B | 116.1 | 116.1 | 116.1 | 116.1 | 116.1 |
| 3B | 150.21 | 150.2 | 150.20 | 150.2 | 150.23 |
| 4B | 143.9 | 143.9 | 143.9 | 143.9 | 143.9 |
| 5B | 122.2 | 122.2 | 122.2 | 122.2 | 122.3 |
| 6B | 119.2 | 119.2 | 119.2 | 119.2 | 119.2 |
| Middle Rings | |||||
| 1 | 139.87, 139.6, 139.52, 139.50, 139.49, 139.38, 139.2 | 139.87, 139.6, 139.5, 139.48, 139.38, 139.2 | 139.86, 139.6, 139.5, 139.49 (2×), 139.48, 139.37, 139.2 | 139.86, 139.6, 139.49 (4×), 139.47, 139.36, 139.2 | 139.85, 139.5, 139.48 (5×), 139.46, 139.36, 139.2 |
| 2 | 151.32, 151.30, 151.27, 151.25, 151.23 (3×) | 151.3, 151.28, 151.26, 151.23, 151.22 (2×) | 151.3, 151.29, 151.27, 151.24, 151.22 (4×) | 151.32, 151.30, 151.27, 151.24, 151.23 (3×), 151.22 (2×) | 151.33, 151.31, 151.28, 151.25, 151.24 (6×) |
| 3 | 107.0, 106.5, 106.38 (3×), 106.37 (2×) | 107.1, 106.5, 106.39, 106.38, 106.37 (2×) | 107.0, 106.4, 106.37 (3×), 106.36 (3×) | 107.0, 106.4, 106.37 (2×), 106.36 (5×) | 107.0, 106.4, 106.3 (8×) |
| 4 | 157.8, 157.7, 157.59, 157.57, 157.56, 157.50, 157.0 | 157.8, 157.6, 157.57, 157.55, 157.49, 157.0 | 157.8, 157.65, 157.58, 157.57, 157.56 (2×), 157.50, 157.0 | 157.8, 157.6, 157.58, 157.56 (4×), 157.50, 157.0 | 157.8, 157.7, 157.58 (3), 157.57 (3×), 157.52, 157.0 |
| 5 | 109.4, 108.85, 108.81, 108.79 (2×), 108.78 (2×) | 109.4, 108.84, 108.80, 108.79, 108.78, 108.77 | 109.4, 108.84, 108.80, 108.78, 108.77 (4×) | 109.4, 108.84, 108.80, 108.78, 108.77 (5×) | 109.4, 108.8, 108.79, 108.76 (7×) |
| 6 | 123.4, 123.3, 123.20 (3×), 123.18 (2×) | 123.4, 123.3, 123.20 (3×), 123.19 | 123.4, 123.3, 123.20 (3×), 123.19 (3×) | 123.4, 123.3, 123.20, 123.18 (6×) | 123.41, 123.35, 123.22 (2), 123.20 (6×) |
| Benzo[ | |||||
| 1 | 100.4 | 100.4 | 100.4 | 100.4 | 100.4 |
| 2 | 156.9 | 156.9 | 156.9 | 156.9 | 156.9 |
| 3 | 105.8 | 105.8 | 105.8 | 105.8 | 105.8 |
| 4 | 147.5 | 147.5 | 147.5 | 147.5 | 136.2 |
| 4a | 136.2 | 136.2 | 136.2 | 136.2 | 147.5 |
| 6 | 162.7 | 162.8 | 162.8 | 162.7 | 162.7 |
| 6a | 114.5 | 114.4 | 114.5 | 114.5 | 114.5 |
| 7 | 115.6 | 115.5 | 115.6 | 115.6 | 115.6 |
| 8 | 148.6 | 148.7 | 148.6 | 148.6 | 148.7 |
| 9 | 154.6 | 155.3 | 154.6 | 154.6 | 154.6 |
| 10 | 108.6 | 108.6 | 108.6 | 108.6 | 108.6 |
| 10a | 130.7 | 130.7 | 130.7 | 130.7 | 130.7 |
| 10b | 120.7 | 120.7 | 120.7 | 120.7 | 120.7 |
1H (800 MHz) NMR Spectroscopic Data of Cladophorols E–I (8–12) in CD3OD
Pharmacological Activitiesa of 3,4,3′,4′-Tetrahydroxy-1,1′-biphenyl (3) and Cladophorols A–I (4–12)
| microbial
strains | |||||||
|---|---|---|---|---|---|---|---|
| compd | no. of rings | MRSA | VREF | Gram– | WTCA | ARCA | |
| 2 | >50 | >50 | >50 | >50 | >50 | NT | |
| 2 | >50 | >50 | >50 | >50 | >50 | 0.7 ± 0.1 | |
| 4 | 13 ± 2 | >50 | >50 | >50 | >50 | 1.9 ± 0.2 | |
| 9 | 1.4 ± 0.3 | >50 | >50 | 46 ± 13 | 46 ± 9 | >2 | |
| 10 | 9 ± 2 | >50 | >50 | >50 | >50 | >2 | |
| 11 | 25 ± 3 | >50 | >50 | >50 | >50 | >2 | |
| 10 | 14 ± 3 | >50 | >50 | >50 | >50 | >2 | |
| 12 | 31 ± 3 | >50 | >50 | >50 | >50 | >2 | |
| 13 | 49 ± 8 | >50 | >50 | >50 | >50 | >2 | |
| 14 | >50 | >50 | >50 | >50 | >50 | >2 | |
The values are expressed as a 95% confidence interval.
Total number of phenyl rings.
Minimal inhibitory concentration (μg/mL). Cell lines are MRSA = methicillin-resistant Staphylococcus aureus; VREF = vancomycin-resistant Enterococcus faecium; Gram–: [Escherichia coli; multiple drug-resistant (MDR) E. coli; MDR Klebsiella pneumonia; MDR K. pneumonia; MDR Acinetobacter baumannii; A. baumannii; MDR Enterobacter aerogenes; MDR Enterobacter cloacae; wild type Pseudomonas aeruginosa]; WTCA = wild type Candida albicans; ARCA = amphotericin B-resistant C. albicans. Details for the positive controls are provided in the Experimental Section.
Half-maximal effective concentration (μg/mL).
Tested only against E. coli.
Figure 7Cytotoxicity of 3–12 against human keratinocytes (HaCaT). The parenthetical values provide the relative cytotoxicities (%) at the maximum concentration tested (60 μg/mL for 9, 50 μg/mL for 3–5, 8, 10, 11, 45 μg/mL for 12, and 20 μg/mL for 6 and 7).